IRESS LIMITED — Director's Dealing 2020

May 21, 2020

==> picture [82 x 63] intentionally omitted <==

The Manager Company Announcements Office Australian Stock Exchange Exchange Centre 20 Bridge Street SYDNEY NSW 2000

22 May 2020

Dear Sir or Madam

RE: APPENDIX 3Y – ANDREW WALSH – CEO & MANAGING DIRECTOR

Please find attached an Appendix 3Y announcement relating to the vesting of Deferred Share Rights and Performance Rights awarded in prior years to Andrew Walsh, CEO & Managing Director as well as the grant of Equity Rights and Performance Rights to Andrew Walsh as authorised at the AGM on 7 May 2020.

Yours sincerely

==> picture [155 x 67] intentionally omitted <==

Peter Ferguson

Group General Counsel & Company Secretary

Iress Limited Corporate Office: Level 16, 385 Bourke Street MELBOURNE VIC 3000 Australia ABN: 47 060 313 359

T +61 3 9018 5800

enquiries@iress.com

www.iress.com

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11

Name of entity	Iress Limited
ABN	47 060 313 359

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Andrew Walsh
Date of last notice	25 November 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change	21 May 2020

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

	No. of securities held prior to change		Ordinary Shares Direct: 361,805 Indirect: 44,909 406,714 Unvested Share/Rights Grants Overview: Deferred Share Rights all Series: 142,018 Performance Rights pre-2019 Series: 320,688 Unvested Rights Grants under revised 2019 executive remuneration framework: Equity Rights: 80,020 Performance Rights: 80,020 Unvested Share/Rights Grants Details: 2016 Series Performance Rights 2016: • 4 year term, granted 7 May 2016, 3 year measurement period commencing 1 Jan 2017: - 60,000 • 4 year term, granted 7 May 2016, 4 year measurement period commencing 1 Jan 2016: - 60,000 2017 Series Deferred Shares Rights 2017: • 3 year term: - 47,575 Performance Rights 2017: • 4 year term, 3 year measurement period commencing 1 Jan 2018: - 54,739 • 4 year term, 4 year measurement period commencing 1 Jan 2017: - 54,739 2018 Series Deferred Shares Rights 2018: • 3 year term, granted 10 May 2018: - 51,707 Performance Rights 2018: • 4 year term, granted 10 May 2018, 3 year measurement period commencing 1 Jan 2019: - 45,605 • 4 year term, granted 10 May 2018, 4 year measurement period commencing 1 Jan 2018: - 45,605 2019 Series Deferred Shares Rights 2019: • 3 year term, granted 9 May 2019: - 42,736 2019 Series – New Framework Equity Rights 2019: • 2 year term, granted 9 May 2019: - 80,020

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

		Performance Rights 2019: • 3 year term, granted 9 May 2019: - 80,020	Performance Rights 2019: • 3 year term, granted 9 May 2019: - 80,020
Class		Ordinary
Number acquired		Vesting of Deferred Share Rights 2017: • 3 year term granted May 2017: - 47,575 Vesting of Performance Rights 2016: • 4 year term, 3 year measurement period granted May 2016: - 37,200 • 4 year term, 4 year measurement period granted May 2016: - 48,000 (*subject to November 2020 retest) Grant of Equity Rights 2020: • 2 year term, granted 21 May 2020: 76,374 Grant of Performance Rights 2020: • 3 year term, granted 21 May 2020, 3 year measurement period commencing 1 Jan 2020: 80,916
Number disposed		Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		N/A
No. of securities held after change		Ordinary Shares Direct: 494,580 Indirect: 44,909 539,489 Unvested Share/Rights Grants Overview: Deferred Share Rights all Series: 94,443 Performance Rights pre-2019 Series: 235,488 Unvested Rights/Grants under revised 2019 executive remuneration framework: Equity Rights: 156,394 Performance Rights: 160,936 Unvested Share/Rights Grants Details: 2016 Series subject to six month retest in Nov 2020 Performance Rights 2016: • 4 year term, granted May 2016, 3 year measurement period commencing 1 Jan 2017:-22,800

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

• 4 year term, granted May 2016, 4 year measurement period commencing 1 Jan 2016: - 12,000 2017 Series Performance Rights 2017: • 4 year term, 3 year measurement period commencing 1 Jan 2018: - 54,739 • 4 year term, 4 year measurement period commencing 1 Jan 2017: - 54,739 2018 Series Deferred Shares Rights 2018: • 3 year term, granted 10 May 2018: - 51,707 Performance Rights 2018: • 4 year term, granted 10 May 2018, 3 year measurement period commencing 1 Jan 2019: - 45,605 • 4 year term, granted 10 May 2018, 4 year measurement period commencing 1 Jan 2018: - 45,605 2019 Series Deferred Shares Rights 2019: • 3 year term, granted 9 May 2019: - 42,736 2019 Series – New Framework Equity Rights 2019: • 2 year term, granted 9 May 2019: - 80,020 Performance Rights 2019: • 3 year term, granted 9 May 2019: – 80,020 2020 Series – New Framework Equity Rights 2020: • 2 year term, granted 21 May 2020, 2 year measurement period commencing 28 Feb 2020 – 28 Feb 2020, (shares provided on exercise of any vested Equity Rights are subject to a mandatory 2 year holding lock (28 February 2022 – 28 February 2024)): – 76,374 Performance Rights 2020: • 3 year term, granted 21 May 2020, 3 year measurement period commencing 1 Jan 2020 – 31 Dec 2022: – 80,916

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Vesting of 2017 Deferred Share Rights Partial vesting of 2016 Performance Rights Grants of 2020 Equity Rights and Performance Rights

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 4

Appendix 3Y Change of Director’s Interest Notice

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior **written clearance was required? **	No
If so, was prior written clearance provided to allow the trade to **proceed during this period? **	N/A
If prior written clearance was provided, on what date was this **provided? **	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 5